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Abstract
Background—No studies have examined whether use of sedation during a Tc-99m 
dimercaptosuccinic acid (DMSA) renal scan reduces patient discomfort.
Objective—To compare discomfort level during a DMSA scan to the discomfort level during 
other frequently performed uroradiologic tests, and to determine whether use of sedation during a 
DMSA scan modifies the level of discomfort.
Materials and methods—We examined the discomfort level in 798 children enrolled in the 
Randomized Intervention for children with Vesicoureteral Reflux (RIVUR) and Careful Urinary 
Tract Infection Evaluation (CUTIE) studies by asking parents to rate their child's discomfort level 
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with each procedure on a scale from 0 to 10. We compared discomfort during the DMSA scan and 
the DMSA image quality between centers in which sedation was used >90% of the time (sedation 
centers), centers in which sedation was used <10% of the time (non-sedation centers), and centers 
in which sedation was used on a case-by-case basis (selective centers).
Results—Mean discomfort level was highest for voiding cystourethrogram (6.4), followed by 
DMSA (4.0), followed by ultrasound (2.4; P<0.0001). Mean discomfort level during the DMSA 
scan was significantly higher at non-sedation centers than at selective centers (P<0.001). No 
difference was apparent in discomfort level during the DMSA scan between sedation centers and 
selective centers (P=0.12), or between the sedation centers and non-sedation centers (P=0.80). 
There were no differences in the proportion with uninterpretable DMSA scans according to 
sedation use.
Conclusion—Selective use of sedation in children 12–36 months of age can reduce the 
discomfort level experienced during a DMSA scan.
Keywords
Anxiolytic; Children; Dimercaptosuccinic acid; Renal scintigraphy; Sedation; Ultrasound; Voiding 
cystourethrogram
Introduction
Use of sedation during the Tc-99m dimercaptosuccinic acid (DMSA) renal scan, a procedure 
performed to evaluate the presence or absence and extent of pyelonephritis and renal 
scarring in children with urinary tract infections (UTIs), remains contentious. Some centers 
routinely use sedation for young children undergoing a DMSA scan, whereas others use 
sedation infrequently. Opponents of routine sedation maintain that a DMSA scan is unlikely 
to cause significant discomfort and that the majority of children can comfortably undergo 
the procedure with adequate preparation and distraction. In contrast, proponents of sedation 
argue that immobilization of uncooperative children, which is often necessary for obtaining 
acceptable images, is best accomplished using sedation.
In contrast to the plethora of studies on the utility of sedation during a voiding 
cystourethrogram (VCUG) [1–13], to our knowledge only two studies have examined the 
discomfort levels during a DMSA scan. Nelson et al. [1] found that parents consider their 
child's discomfort level during a VCUG to be significantly higher than discomfort during 
DMSA scan, and higher than discomfort during a renal sonogram. Train et al. [6] reported 
that appropriate patient preparation and distraction can successfully reduce the proportion of 
children undergoing sedation for DMSA. No studies have examined whether the use of 
sedation during the imaging portion of the DMSA scan is associated with less discomfort.
Our objectives were (1) to compare the level of discomfort during a DMSA scan with the 
level of discomfort experienced during other frequently performed uroradiologic tests 
(sonography and voiding cystourethrography), (2) to compare the level of discomfort 
experienced by young children during a DMSA scan at centers that do and do not routinely 
use sedation, and (3) to compare the quality of the DMSA scans obtained at centers that do 
and do not routinely use sedation.
Shaikh et al. Page 2
Pediatr Radiol. Author manuscript; available in PMC 2017 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Materials and methods
We examined the parent-perceived degree of discomfort during uroradiologic imaging tests 
performed in 607 children enrolled in the Randomized Intervention for children with 
Vesicoureteral Reflux (RIVUR) trial and 195 children enrolled in the Careful Urinary Tract 
Infection Evaluation (CUTIE) study. The methods of the RIVUR trial and CUTIE study 
have been described [14–16]. Briefly, we enrolled children ages 2–72 months who presented 
with a first or second UTI from both primary and subspecialty care settings at clinical trial 
centers throughout North America. Children with grades I–IV vesicoureteral reflux (VUR) 
were enrolled in the RIVUR study whereas those without VUR were enrolled in the parallel 
CUTIE study. Not all RIVUR sites participated in the CUTIE study. Each child in these 
studies had sonography, a VCUG, and a DMSA scan soon after the index UTI. In both 
studies, the DMSA scan was repeated 2 years after the index UTI. In the RIVUR study, a 
DMSA scan was performed 1 year and a VCUG performed 2 years after the index UTI. 
Both studies were approved by institutional review boards of the participating institutions. 
Collection of data regarding discomfort during imaging tests was planned before patient 
enrollment started for the RIVUR and CUTIE studies.
Following each imaging test, we asked parents to rate how much discomfort their child had 
with each of these procedures on a rating scale (Fig. 1). Study coordinators recorded 
whether sedation was used and, if so, they ascertained the type of sedation by reviewing the 
child's medical records. We included only imaging tests for which the discomfort 
questionnaire was obtained within 2 weeks of the imaging test. The only exception to this 
rule was the baseline VCUG; some discomfort questionnaires were completed 2 weeks or 
more after the baseline VCUG (maximum of 112 days). We included all imaging tests 
conducted at any time during the 2-year study period except for four cases with missing data 
regarding either the sedative used or the level of discomfort.
The DMSA scan has three phases. In the first phase (injection), DMSA is injected 
intravenously. The second phase (distribution), during which DMSA is distributed to the 
tissues, takes 1.5–3 h. During this time the child usually leaves the radiology suite. In the 
third phase (imaging), which takes 30–60 min, uncooperative children often need to be 
immobilized by their parents or by using a papoose board. If used, sedation is administered 
right before the third phase. Sites that use sedation provided additional information 
regarding sedation to patients. Otherwise, because there was a common standard operating 
procedure for performing the DMSA across all sites, as well as a standardized description of 
the procedure in the common consent for the study, we do not expect large differences in the 
preparation for the test or in the procedure among centers. The time required for the imaging 
portion of the test was likely relatively constant across institutions because the counts 
required for each image were specified in the procedure manual. Information regarding child 
life specialist participation during the DMSA scan was not collected on a case-by-case basis. 
However, after the study was completed, we queried the principal investigators and research 
coordinators at each site regarding child-life involvement at their respective sites.
We defined “sedation centers” as centers that used sedation for >90% of DMSA scans. 
Similarly, we defined “non-sedation centers” as those that used sedation in <10% of DMSA 
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scans. The remaining centers, in which the use sedation was more selective, were 
categorized as “selective centers.” All six selective centers had policies for sedation that 
were based on the child's age: two sites routinely sedated children 1–3 years of age, two 
sedated children <4 years of age, one sedated children <5 years of age and one sedated 
children 6 months to 5 years of age.
DMSA quality was categorized as adequate or inadequate by two independent reference 
radiologists who were unaware whether sedation was used. Disagreements were resolved by 
discussion. Inadequate scans were those that were uninterpretable because of poor quality 
(most often because of excessive movement during the procedure).
Discomfort levels were compared using linear models adjusted for age, race, gender, site, 
insurance type, primary caregiver's education level, and fever. We used generalized 
estimated equations (with exchangeable correlation structure) to account for correlation of 
multiple observations in the same child. Repeated measures analysis of variance (ANOVA) 
was used to compare discomfort levels among centers. Univariable and multivariable logistic 
regression was used to investigate the relationship between use of sedation and adequacy of 
DMSA scans.
Results
Table 1 describes the clinical and demographic characteristics of 798 children in the analytic 
sample. Overall, 725 (91%) were girls and 612 (77%) were white; median age was 12 
months. A total of 1,215 DMSA scans, 1,159 VCUGs and 768 renal US exams were 
performed during the study period. A total of 27% of DMSA scans were conducted on the 
same day as a VCUG. Sedation was used in 390 (32%) of the 1,215 DMSA scans, including 
77 (92%) of the 84 DMSA scans performed at the 3 sedation centers, 5 (1%) of the 631 
DMSA scans performed at the 10 non-sedation centers, and 308 (62%) of the 500 DMSA 
scans performed at the 6 selective centers. Sedation was not used for any of the US 
examinations. Similarly, 95%) (1,104/1,159) VCUGs were performed without sedation.
Data regarding child-life participation were available for 18 of the 19 participating sites; 
fewer than 1% of DMSA scans were performed at the site with missing data. Of the 
responding centers, child life was present routinely at 33% (1 of 3) of sedation centers, 22% 
(2 of 9) of non-sedation centers and 33% of selective centers (2 of 6).
Discomfort level comparison among the three imaging tests
The mean discomfort level (confidence interval) on a scale of 0 to 10 was highest for VCUG 
(6.4, confidence interval [CI] 6.2–6.5), followed by DMSA (4.0, CI 3.8–4.1) and US exam 
(2.4, CI 2.1–2.6), with P<0.001 for all three pairwise comparisons (Fig. 2).
Effect of sedation on discomfort during DMSA
Mean discomfort level (confidence interval) reported by children's parents was 4.1 (3.5–4.7) 
at sedation centers, 4.2 (4.0–4.5) at non-sedation centers and 3.6 (3.3–3.8) at selective 
centers; the mean discomfort level at non-sedation centers was significantly higher than that 
observed at selective centers (P<0.001). No significant difference in discomfort level was 
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apparent between sedation centers and selective centers (P=0.12) or between sedation 
centers and non-sedation centers (P=0.80). Sedation, non-sedation and selective centers 
differed systematically according to patient characteristics (age, gender, race, ethnicity, 
maternal education, insurance type, and presence of fever at the time of the index UTI). 
Nevertheless adjusting for these variables in the analysis did not alter our findings; adjusted 
P values for non-sedation vs. selective, sedation vs. selective, and sedation vs. non-sedation 
centers were <0.0001, 0.17, and 0.55, respectively.
Factors associated with use of sedation at selective centers
Sedation was significantly more likely to be used in younger children. At the selective 
centers, mean age of sedated children ranged from 18 months to 31 months, whereas mean 
age of non-sedated children ranged from 43 months to 48 months. Race, gender, ethnicity, 
maternal insurance, maternal education level, and fever at the time of the index UTI were 
not associated with the use of sedation. Specifically, children 12–36 months of age were 
significantly more likely to be sedated than children outside this age range (odds ratio 2.32; 
95% CI 1.83, 2.94).
Efficacy of sedatives used
At selective centers (Fig. 3), children who received a combination of fentanyl-pentobarbital-
midazolam had significantly lower discomfort levels than those who received pentobarbital 
alone (2.7 vs. 3.8), choral hydrate (2.7 vs. 4.7) or midazolam-pentobarbital (2.7 vs. 5.5). 
Adjusted P-values were 0.03, <0.001 and <0.001, respectively. Adjustment for site was not 
performed because most sites used only one or two sedative types. We were not able to 
compare various sedatives because 96% of sedated children received propofol.
Effect of sedation on DMSA quality
Radiologists categorized 22 of 1,215 DMSA scans (2%) as being uninterpretable. There 
were 0/84 (0%) uninterpretable DMSA scans at sedation centers, 12/631 (2%) at non-
sedation centers and 10/500 (2%) at selective centers (P=0.58). Use of sedation was not 
associated with interpretability of the scan: 1.5% of scans in which sedation was used versus 
1.9% of scans in which sedation was not used were judged to be uninterpretable (P=0.89). 
Similarly, at selective centers there was no difference in the proportion of uninterpretable 
scans performed with and without sedation (P=0.41).
Factors associated with DMSA quality
The only variable associated with DMSA quality was age; mean age of children with 
uninterpretable scans was significantly lower than the mean age of children with 
interpretable scans (20 months vs. 34 months, P=0.003).
Discussion
We found no difference in the perceived discomfort level or scan quality at centers that did 
or did not routinely use sedation for the imaging portion of the DMSA scan. Accordingly, 
routine use of sedation does not appear to be particularly beneficial. We also found that 
children scanned at centers where the use of sedation was more selective (determined mostly 
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by age) had less discomfort than children at centers that routinely used sedation or centers 
that seldom used sedation. This suggests that restricting sedation to individual children 12–
36 months of age who are unlikely to hold still during the study may be the best overall 
strategy to reduce discomfort. Developmentally, children in the 12- to 36-month age range 
have more difficulty remaining motionless for a prolonged period compared with infants, 
who often fall asleep after a period of crying (provided that they are well-fed during the 
distribution phase of the study), or compared with older children who can be distracted more 
easily (e.g., by a movie or game). The lower discomfort scores from centers that use sedation 
selectively was likely because these centers maximized the benefits of sedation while 
minimizing its risks; the perceived discomfort levels during the DMSA scan at such centers 
were much closer to the discomfort levels of a US scan than that of a VCUG.
At selective centers there was significant variation in the perceived discomfort level 
according to the sedative used. Children who received an agent containing an analgesic (e.g., 
fentanyl) had lower levels of perceived discomfort than children receiving agents containing 
only sedatives or anxiolytics. Because allocation of agents used for sedation was not 
random, we cannot make definitive conclusions regarding the efficacy of various sedatives. 
Nevertheless our data suggest that the combination of fentanyl, midazolam and pentobarbital 
might be more effective than other sedative combinations.
The perceived discomfort level of the DMSA scan fell between that of the US and the 
VCUG tests, which is consistent with findings from Nelson et al. [1]. This is not entirely 
surprising. During a DMSA scan an intravenous line is placed and some children are 
restrained. During a VCUG, urinary catheterization is performed and all children are 
restrained. During a US examination, no invasive procedures are performed and children are 
generally not restrained.
Because these data are observational, our conclusions are limited. Sedation centers used 
propofol almost exclusively, limiting the generalizability of our findings. Unmeasured 
confounders such as the degree of preparation before the procedure and the use of distraction 
during the procedure could have differed between centers. However there was little apparent 
difference among centers regarding the preparation for the test, the actual procedures, or the 
use of child life specialists. The rating scale we used to measure discomfort has not been 
validated; however, the use of rating scales for pain is widely accepted. We did not examine 
the effect of sedation on the time required to perform the DMSA scan; doing so in future 
studies might provide helpful information. The relative efficacy of various sedatives also 
merits further study. Finally, we did not ask about adverse events related to the use of 
sedation.
Conclusion
It appears that selective use of sedation during a DMSA scan might reduce the perceived 
discomfort level experienced by children during this procedure. The use of sedation did not 
reduce the proportion of DMSA scans that were uninterpretable.
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Fig. 1. Instrument used to assess discomfort with imaging tests
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Fig. 2. 
Graph shows perceived discomfort level for three frequently performed imaging tests of the 
urinary tract. DMSA dimercaptosuccinic acid renal scan, VCUG voiding cystourethrogram
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Fig. 3. Graph shows efficacy of the sedatives used in selective centers
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Table 1
Demographic and clinical characteristics of the children included
Characteristic Total (n=798) n (%)
Age
 2–24 months 534 (67)
 24–72 months 264 (33)
Gender
 Female 725 (91)
 Male 73 (9)
Race
 White 612 (77)
 Non-white 175 (22)
 Missing 11 (1)
Ethnicity
 Hispanic 118 (15)
 Not Hispanic 677 (85)
 Missing 3 (<1)
Primary caregiver education
  High school graduate or less 226 (28)
  >High school 567 (71)
  Missing 5 (1)
Index UTI
 Febrile 667 (84)
 Afebrile 131 (16)
UTI urinary tract infection
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